ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

In Brief: Ford Decides Against Asking For Recision Of NCI Funds After Congress Overrides Verto

October 8, 1976

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

June 12, 1992

Obama Signs Spending Bill for FY09

March 13, 2009

Duke Tells ACS The Check for $437,400 Is In The Mail

December 10, 2010

Also Senate, House committees request further research, reports from NCI.

September 19, 2003